| Hsd:SD |
pancreas weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
pancreas mass |
female |
84.0 days
| 5 |
390.0 |
mg |
40.0 |
89.44 |
post excision weight measurement |
|
|
106456 |
3025 |
| Hsd:SD |
spleen weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
spleen mass |
male |
84.0 days
| 5 |
0.25 |
g |
0.02 |
0.04 |
post excision weight measurement |
|
|
106458 |
3025 |
| Hsd:SD |
thyroid gland weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
thyroid gland mass |
male |
84.0 days
| 5 |
0.01 |
g |
0.0 |
0.0 |
post excision weight measurement |
|
|
106474 |
3025 |
| Hsd:SD |
both testes wet weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
testis mass |
male |
84.0 days
| 12 |
0.99 |
g |
0.01 |
0.03 |
post excision weight measurement |
|
|
106488 |
3025 |
| Hsd:SD |
prostate gland weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
prostate mass |
male |
84.0 days
| 12 |
0.25 |
g |
0.04 |
0.14 |
post excision weight measurement |
|
|
106492 |
3025 |
| Hsd:SD |
spleen weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (22 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
spleen mass |
female |
84.0 days
| 10 |
0.28 |
% |
0.03 |
0.09 |
post excision weight measurement |
|
|
105900 |
3021 |
| Hsd:SD |
spleen weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (100 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
spleen mass |
female |
84.0 days
| 10 |
0.28 |
% |
0.03 |
0.09 |
post excision weight measurement |
|
|
105902 |
3021 |
| Hsd:SD |
spleen weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (1000 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
spleen mass |
female |
84.0 days
| 10 |
0.27 |
% |
0.02 |
0.05 |
post excision weight measurement |
|
|
105906 |
3021 |
| Hsd:SD |
brain weight to body weight ratio |
vehicle control condition (5 ml/kg) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
brain mass |
female |
84.0 days
| 10 |
0.74 |
% |
0.03 |
0.1 |
post excision weight measurement |
|
|
105908 |
3021 |
| Hsd:SD |
brain weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (22 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
brain mass |
female |
84.0 days
| 10 |
0.75 |
% |
0.06 |
0.18 |
post excision weight measurement |
|
|
105912 |
3021 |
| Hsd:SD |
liver weight as percentage of body weight |
vehicle control condition (5 ml/kg) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
liver mass |
female |
84.0 days
| 10 |
3.65 |
% |
0.2 |
0.63 |
post excision weight measurement |
0.0 |
|
105720 |
3021 |
| Hsd:SD |
liver weight as percentage of body weight |
2,3,7,8-tetrachlorodibenzo-p-dioxin (300 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
liver mass |
female |
84.0 days
| 10 |
5.03 |
% |
0.37 |
1.17 |
post excision weight measurement |
0.0 |
|
105724 |
3021 |
| Hsd:SD |
thymus weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (3 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
thymus mass |
female |
84.0 days
| 10 |
1.47 |
mg/g |
0.24 |
0.76 |
post excision weight measurement |
|
|
105886 |
3021 |
| Hsd:SD |
thymus weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (300 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
thymus mass |
female |
84.0 days
| 10 |
1.03 |
mg/g |
0.19 |
0.6 |
post excision weight measurement |
|
|
105892 |
3021 |
| Hsd:SD |
spleen weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (3 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
spleen mass |
female |
84.0 days
| 10 |
0.29 |
% |
0.02 |
0.07 |
post excision weight measurement |
|
|
105898 |
3021 |
| Hsd:SD |
both ovaries weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (1000 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
ovary mass |
female |
84.0 days
| 10 |
0.04 |
% |
0.01 |
0.03 |
post excision weight measurement |
|
|
105930 |
3021 |
| Hsd:SD |
liver weight as percentage of body weight |
2,3,7,8-tetrachlorodibenzo-p-dioxin (3 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
liver mass |
female |
84.0 days
| 10 |
3.65 |
% |
0.16 |
0.51 |
post excision weight measurement |
0.0 |
|
105721 |
3021 |
| Hsd:SD |
liver weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
liver mass |
male |
84.0 days
| 5 |
4.61 |
g |
0.25 |
0.56 |
post excision weight measurement |
|
|
106442 |
3025 |
| Hsd:SD |
thyroid gland weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
thyroid gland mass |
female |
84.0 days
| 5 |
0.01 |
g |
0.0 |
0.0 |
post excision weight measurement |
|
|
106476 |
3025 |
| Hsd:SD |
adrenal gland weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
adrenal gland mass |
female |
84.0 days
| 5 |
26.0 |
mg |
2.0 |
4.47 |
post excision weight measurement |
|
|
106480 |
3025 |
| Hsd:SD |
pituitary gland weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
pituitary gland mass |
female |
84.0 days
| 5 |
0.01 |
g |
0.0 |
0.0 |
post excision weight measurement |
|
|
106484 |
3025 |
| Hsd:SD |
thymus weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (100 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
thymus mass |
female |
84.0 days
| 10 |
1.29 |
mg/g |
0.23 |
0.73 |
post excision weight measurement |
|
|
105890 |
3021 |
| Hsd:SD |
spleen weight to body weight ratio |
vehicle control condition (5 ml/kg) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
spleen mass |
female |
84.0 days
| 10 |
0.3 |
% |
0.03 |
0.09 |
post excision weight measurement |
|
|
105896 |
3021 |
| Hsd:SD |
spleen weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (300 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
spleen mass |
female |
84.0 days
| 10 |
0.28 |
% |
0.02 |
0.07 |
post excision weight measurement |
|
|
105904 |
3021 |
| Hsd:SD |
brain weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (1000 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
brain mass |
female |
84.0 days
| 10 |
0.84 |
% |
0.05 |
0.16 |
post excision weight measurement |
|
|
105918 |
3021 |
| Hsd:SD |
kidney weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
kidney mass |
female |
84.0 days
| 5 |
0.81 |
g |
0.06 |
0.13 |
post excision weight measurement |
|
|
106448 |
3025 |
| Hsd:SD |
heart weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
heart mass |
male |
84.0 days
| 5 |
0.38 |
g |
0.02 |
0.04 |
post excision weight measurement |
|
|
106450 |
3025 |
| Hsd:SD |
thymus weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
thymus mass |
male |
84.0 days
| 5 |
0.16 |
g |
0.02 |
0.04 |
post excision weight measurement |
|
|
106462 |
3025 |
| Hsd:SD |
adrenal gland weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
adrenal gland mass |
male |
84.0 days
| 5 |
13.0 |
mg |
4.0 |
8.94 |
post excision weight measurement |
|
|
106478 |
3025 |
| Hsd:SD |
both ovaries weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
ovary mass |
female |
84.0 days
| 12 |
0.05 |
g |
0.0 |
0.01 |
post excision weight measurement |
|
|
106486 |
3025 |
| Hsd:SD |
epididymides weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
epididymis mass |
male |
84.0 days
| 12 |
0.56 |
g |
0.06 |
0.21 |
post excision weight measurement |
|
|
106490 |
3025 |
| Hsd:SD |
thymus weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (22 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
thymus mass |
female |
84.0 days
| 10 |
1.49 |
mg/g |
0.27 |
0.85 |
post excision weight measurement |
|
|
105888 |
3021 |
| Hsd:SD |
thymus weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (1000 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
thymus mass |
female |
84.0 days
| 10 |
0.65 |
mg/g |
0.18 |
0.57 |
post excision weight measurement |
|
|
105894 |
3021 |
| Hsd:SD |
brain weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (3 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
brain mass |
female |
84.0 days
| 10 |
0.76 |
% |
0.03 |
0.09 |
post excision weight measurement |
|
|
105910 |
3021 |
| Hsd:SD |
brain weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (100 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
brain mass |
female |
84.0 days
| 10 |
0.77 |
% |
0.05 |
0.15 |
post excision weight measurement |
|
|
105914 |
3021 |
| Hsd:SD |
both ovaries weight to body weight ratio |
vehicle control condition (5 ml/kg) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
ovary mass |
female |
84.0 days
| 10 |
0.05 |
% |
0.01 |
0.03 |
post excision weight measurement |
|
|
105920 |
3021 |
| Hsd:SD |
both ovaries weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (22 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
ovary mass |
female |
84.0 days
| 10 |
0.05 |
% |
0.01 |
0.04 |
post excision weight measurement |
|
|
105924 |
3021 |
| Hsd:SD |
both ovaries weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (100 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
ovary mass |
female |
84.0 days
| 10 |
0.04 |
% |
0.01 |
0.02 |
post excision weight measurement |
|
|
105926 |
3021 |
| Hsd:SD |
liver weight as percentage of body weight |
2,3,7,8-tetrachlorodibenzo-p-dioxin (22 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
liver mass |
female |
84.0 days
| 10 |
4.16 |
% |
0.21 |
0.65 |
post excision weight measurement |
0.0 |
|
105722 |
3021 |
| Hsd:SD |
liver weight as percentage of body weight |
2,3,7,8-tetrachlorodibenzo-p-dioxin (100 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
liver mass |
female |
84.0 days
| 10 |
4.69 |
% |
0.34 |
1.06 |
post excision weight measurement |
0.0 |
|
105723 |
3021 |
| Hsd:SD |
liver weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
liver mass |
female |
84.0 days
| 5 |
4.35 |
g |
0.41 |
0.92 |
post excision weight measurement |
|
|
106444 |
3025 |
| Hsd:SD |
kidney weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
kidney mass |
male |
84.0 days
| 5 |
0.88 |
g |
0.03 |
0.07 |
post excision weight measurement |
|
|
106446 |
3025 |
| Hsd:SD |
pancreas weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
pancreas mass |
male |
84.0 days
| 5 |
280.0 |
mg |
40.0 |
89.44 |
post excision weight measurement |
|
|
106454 |
3025 |
| Hsd:SD |
thymus weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
thymus mass |
female |
84.0 days
| 5 |
0.15 |
g |
0.02 |
0.04 |
post excision weight measurement |
|
|
106464 |
3025 |
| Hsd:SD |
brain weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
brain mass |
male |
84.0 days
| 5 |
0.48 |
g |
0.02 |
0.04 |
post excision weight measurement |
|
|
106466 |
3025 |
| Hsd:SD |
lung weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
lung mass |
female |
84.0 days
| 5 |
0.73 |
g |
0.13 |
0.29 |
post excision weight measurement |
|
|
106472 |
3025 |
| Hsd:SD |
pituitary gland weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
pituitary gland mass |
male |
84.0 days
| 5 |
0.0 |
g |
0.0 |
0.0 |
post excision weight measurement |
|
|
106482 |
3025 |
| Hsd:SD |
thymus weight to body weight ratio |
vehicle control condition (5 ml/kg) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
thymus mass |
female |
84.0 days
| 10 |
1.5 |
mg/g |
0.35 |
1.11 |
post excision weight measurement |
|
|
105884 |
3021 |
| Hsd:SD |
brain weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (300 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
brain mass |
female |
84.0 days
| 10 |
0.76 |
% |
0.06 |
0.18 |
post excision weight measurement |
|
|
105916 |
3021 |
| Hsd:SD |
both ovaries weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (3 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
ovary mass |
female |
84.0 days
| 10 |
0.05 |
% |
0.01 |
0.03 |
post excision weight measurement |
|
|
105922 |
3021 |
| Hsd:SD |
both ovaries weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (300 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
ovary mass |
female |
84.0 days
| 10 |
0.04 |
% |
0.01 |
0.04 |
post excision weight measurement |
|
|
105928 |
3021 |
| Hsd:SD |
heart weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
heart mass |
female |
84.0 days
| 5 |
0.39 |
g |
0.03 |
0.07 |
post excision weight measurement |
|
|
106452 |
3025 |
| Hsd:SD |
spleen weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
spleen mass |
female |
84.0 days
| 5 |
0.3 |
g |
0.02 |
0.04 |
post excision weight measurement |
|
|
106460 |
3025 |
| Hsd:SD |
brain weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
brain mass |
female |
84.0 days
| 5 |
0.67 |
g |
0.06 |
0.13 |
post excision weight measurement |
|
|
106468 |
3025 |
| Hsd:SD |
lung weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
lung mass |
male |
84.0 days
| 5 |
0.59 |
g |
0.11 |
0.25 |
post excision weight measurement |
|
|
106470 |
3025 |
